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Ebola virus glycoprotein (EGP) has been implicated for the induction of cytotoxicity and injury in vascular cells. On the other hand, EGP has
also been suggested to inducemassive cell rounding and detachment from the plastic surface by downregulating cell adhesionmolecules without
causing cytotoxicity. In this study, we have examined the cytotoxic role of EGP in primary endothelial cells by transduction with a replication-
deficient recombinant adenovirus expressing EGP (Ad-EGP). Primary human cardiac microvascular endothelial cells (HCMECs) transduced
with Ad-EGP displayed loss of cell adhesion from the plastic surface followed by cell death. Transfer of conditioned medium from EGP-
transduced HCMEC into naive cells did not induce loss of adhesion or cell death, suggesting that EGP needs to be expressed intracellularly to
exert its cytotoxic effect. Subsequent studies suggested that HCMEC death occurred through apoptosis. Results from this study shed light on the
EGP-induced anoikis in primary human cardiac endothelial cells, which may have significant pathological consequences.
D 2004 Elsevier Inc. All rights reserved.Keywords: Ebola virus glycoprotein; Anoikis; Human cardiac microvascular endothelial cellIntroduction
Ebola virus is named for a river in the Congo and
belongs to Filoviridae family. Outbreaks of hemorrhagic
fever caused by the Ebola virus are associated with high
mortality rates, a distinguishing feature of this human
pathogen. There are four different Ebola virus subtypes.
Among these, Ebola Zaire seems to be the most virulent,
killing approximately 90% of the infected individuals
(Sullivan et al., 2000). Afflicted patients present flu-like
symptoms and bleeding, and death frequently occurs within
10 days of initial infection (Bwaka et al., 1999). Ebola
virus may enter through minor lesions on the skin or mucus
membranes, and subsequently access through the blood
directly or via the lymphatic system (Schnittler and Feld-0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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ations to account for the extreme virulence of Ebola virus
in humans. Earlier studies suggested a nonspecific destruc-
tion of the endothelium as a possible mechanism of Ebola
virus-mediated pathogenesis. Destruction of primary human
endothelial cell and organ culture from Marburg virus
(another member of Filoviridae family) replication also
suggests as a possible mechanism for the hemorrhagic
disease and shock syndrome (Schnittler et al., 1993). An
effective vaccine or antiviral treatment for this devastating
disease does not exist at present. Recently, Sullivan et al.
(2003b) reported protection against a lethal Ebola virus
challenge in nonhuman primates after a single immuniza-
tion with Ebola GP/nucleoprotein (NP). These promising
results generate hope for the development of vaccine
against Ebola virus infection in humans.
Ebola virus contains a negative-strand RNA genome that
encodes seven polypeptides NP, VP35, VP40, glycoprotein
(GP), VP30, VP24, and an RNA-dependent RNA polymer-
ase (L) (Takada and Kawaoka, 2001). Ebola virus envelope
glycoprotein (EGP), which is responsible for receptor
binding and fusion of the virus with host cells (Chan et
R.B. Ray et al. / Virology 321 (2004) 181–188182al., 2000a; Sullivan et al., 2003a, 2003b; Takada and
Kawaoka, 2001; Volchkov, 1999; Wool-Lewis and Bates,
1998), has been described as a candidate for the induction
of cytotoxicity and injury of vascular cells (Sullivan et al.,
2003a; Yang et al., 2000). This functional effect was
mapped to a serine–threonine-rich, mucin-like domain of
EGP. On the other hand, Simmons et al. (2002) suggested
that EGP induces massive cell rounding and detachment by
the downregulation of cell adhesion molecules without
causing cytotoxicity. An O-glycosylated region (or mucin-
like domain) was implicated to induce loss of cell adher-
ence. Thus, understanding of EGP-mediated pathogenesis is
important and merits additional investigation. Ebola virus
spreads to the vascular endothelium, where virus glycopro-
tein-mediated cellular cytotoxicity may occur, causing vas-
cular destruction in the later stages of disease. Increased
paraendothelial permeability may be one of the most
important events during shock development and is probably
a major cause of death in filovirus hemorrhagic fever
(Klenk, 1999). However, the mechanism underlying the
enhanced vascular permeability that causes hemorrhagic
fever in humans remains enigmatic. In this study, we have
examined whether EGP expression exerts control on endo-
thelial cell growth. Our results suggested that primary
human cardiac microvascular endothelial cells (HCMECs)
are highly susceptible to apoptosis induced by altered
expression of cell-adhesion molecules upon intracellular
EGP expression. Therefore, EGP appears to induce anoikis
or detachment-induced apoptosis in HCMEC, which may
have significant pathological consequences.Fig. 1. (A) Expression of Ebola virus glycoprotein in transduced HCMEC. Ad-hga
48 h. Cells were lysed and subjected to Western blot analysis under reducing co
chemiluminescence. The positions of pre-GP (approximately 160 kDa), GP1 (appr
on the right. The molecular weights of the protein bands were ascertained from th
Surface immunofluorescence of Ebola virus glycoprotein. Ad-EGP-infected 293
expression by surface immunofluorescence using a specific monoclonal antibody (
GFP displayed EGP on the cell surface (panel c); however, GFP and EGP did noResults and discussion
Transduction of Ebola virus glycoprotein by
replication-deficient recombinant adenovirus
To examine the expression of EGP from recombinant
adenovirus (Ad-EGP), HCMECs were transduced with Ad-
EGP (20 moi) and cell lysates were analyzed by Western blot
using a specific rabbit antibody. Replication-deficient recom-
binant adenovirus expressing h-galactosidase (Adh-gal) was
kindly provided by Bert Vogelstein (The John Hopkins
University, MD) and used as a negative control. Results from
Western blot (Fig. 1A) suggested expression of two major
polypeptide bands of approximately 160 and 130 kDa repre-
senting the precursor form of GP and GP1, respectively; and a
minor polypeptide band of approximately 24 kDa represent-
ing GP2. On the other hand, Adh-gal-transduced cell lysates
did not display a detectable polypeptide band even after
longer exposure of the blot to X-ray film.
To examine the cell surface expression of EGP, HCMECs
were transduced with Ad-EGP or Adh-gal. After 24 h, cells
were examined for EGP expression by surface immunoflu-
orescence. Cells (nonpermeabilized) were incubated with
anti-EGP mouse monoclonal antibody (13F6-1–2) followed
by incubation with anti-mouse immunoglobulin (Ig) conju-
gated to Alexa 568 for fluorescent microscopy. All of the
cells displayed both GFP (intracellular green color) and
Alexa 568 (red color) suggesting transduced GFP-producing
cells express EGP on the cell surface (Fig. 1B). The Adh-
gal-transduced control cells were treated similarly and didl (lane 1) or Ad-EGP (lane 2) was used to infect HCMEC and incubated for
nditions using a rabbit antiserum to Ebola virus glycoprotein, followed by
oximately 130 kDa), and GP2 (approximately 24 kDa) are shown by arrows
e migration of standard protein molecular weight markers (Invitrogen). (B)
cells were incubated for 48 h. Transduced cells were examined for EGP
panel a) and GFP expression (panel b). The majority of the cells expressing
t merge as expected.
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GFP expression was observed, as expected.
Ebola virus glycoprotein induces cellular cytotoxicity
To investigate whether EGP expression alters primary
HCMEC morphology or viability, we transduced HCMEC
with Ad-EGP or Adh-gal as a negative control at different
doses. Human umbilical vein endothelial cells (HUVECs)
were also included in parallel as a different source of
endothelial cells for comparison. Interestingly, transduction
with Ad-EGP in a dose-dependent manner displayed ap-
proximately 10-fold higher sensitivity for mediating cyto-
pathic effect in HCMEC when compared to that of HUVEC
under similar experimental conditions. Transduction of
HCMEC with Ad-EGP (20 moi) detached >90% cells from
a monolayer culture within 24–48 h with a significant level
of cell death occurring within 4–5 days (Fig. 2). On the
other hand, cells transduced similarly with Adh-gal did not
induce loss of adhesion or cell death. Both cell types
displayed similar transduction efficiency when monitored
for GFP expression by fluorescence microscopy. Results
from these studies suggested that endothelial cells derived
from human cardiac and umbilical cords exhibit markedly
different levels of cytopathic effect upon EGP transduction;
with HCMEC being highly susceptible to EGP-induced cell
death as compared to HUVEC. Further work is necessary to
understand the basis for difference in cytopathic effect
between these cell types. Cell rounding was observed to
be directly dependent upon an increased multiplicity of
infection of Ad-EGP. Cell viability and growth analysis
indicated that detached cells fail to adhere onto a new cell
culture plate when transferred within 24–48 h post trans-
duction and cell death occurred within 4–5 days. GeisbertFig. 2. Effect of EGP expression on endothelial cell viability. Cell viability
was measured by trypan blue exclusion after Ad-EGP transduction of
HCMEC (x–x) or HUVEC (n–n). Ad-hgal was used similarly as a
negative control to transduce HCMEC (.–.) or HUVEC (D–D) for
comparison.et al. (2000) reported earlier that they did not detect
apoptosis after infection of human microvascular endothe-
lial cells (HMVEC) with a single dose of Ebola virus
infection. In our experiments, nonreplicating recombinant
adenovirus consistently induced apoptosis in HCMEC. The
difference between our results with that of others is likely
for the lack of sufficient dose for virus infectivity in
HMVEC. Although human embryonic kidney (293) cells
transduced with Ad-EGP rounded and reattached in new
matrigel-coated plate (Simmons et al., 2002), we did not
observe this phenomenon with the HCMEC used in our
experiment. This apparent difference may be due to cell
types used in these two studies and the expression level of
EGP. Culture medium from cells collected after 24, 48, and
72 h of transduction with Ad-EGP was incubated with naive
HCMEC to examine whether the absence of ongoing
intracellular synthesis of EGP can exert a cytopathic effect.
Results from three independent experiments suggested that
HCMEC death does not occur from the conditioned media
(data not shown). Thus, EGP needs to be expressed intra-
cellularly to exert its cytotoxic effect. We further analyzed
the effect of EGP expression in a human monocyte–
macrophage-derived cell line (THP-1) by transduction with
Ad-EGP at different multiplicity of infections. THP-1 cells
did not display cell death at up to 10 days of observation.
These results suggested that EGP does not induce cytotox-
icity in cultured monocytes or macrophages in our exper-
imental conditions.
Transduction with Ad-EGP modulates human extracellular
matrix and adhesion molecule-related genes
Because we have observed HCMEC rounding upon EGP
expression, we became interested to know the global status
of the extracellular matrix (ECM) and cell adhesion mole-
cules. A cDNA macroarray was used to examine the mod-
ulation of extracellular matrix and adhesion molecules in
EGP-transduced HCMEC. Cells were separately transduced
with Adh-gal for comparison. A biotin-16-dUTP cDNA
probe was synthesized from total cellular RNA isolated from
HCMEC 24 h after infection with Ad-EGP (experimental) or
Adh-gal (negative control) by RT-PCR. Differential expres-
sion was determined as fold deviation from negative control
after normalizing all spots and average relative intensities of
the housekeeping genes on Ad-EGP and Adh-gal transduced
mRNA hybridized membranes (Table 1).
Among the cell membrane adhesion molecules examined,
integrin h5 was approximately 6.7-fold lower, immunoglob-
ulin (Ig) superfamily gene carcinoembryonic antigen-related
adhesion molecule 5 (CEACAM5) was approximately 8.5-
fold lower, and platelet–endothelial cell adhesion molecule
(PECAM 1) was approximately 14.8-fold lower in EGP-
expressing cells. On the other hand, MICA gene, integrin a5
(fibronectin receptor), and integrin a8 were similar in both
EGP- and h-gal-expressing cells (not shown in Table 1).
Other cell membrane adhesion molecules were decreased
Table 1
Ebola virus glycoprotein-transduced gene modulation in HCMEC
Functional gene grouping Fold changea
Cell membrane adhesion molecules
Integrins
ITG a1, 2, 2b, 3, 4, 6–11 2.5 to 3.5
ITG h 1–4, 6–8 2.2 to 3.7
ITG h5 6.7
Immunoglobulin (Ig) superfamily
CEACAM5 8.5
DCC, ICAM1, NCAM, NRCAM, VCAM1 2.5 to 3.5
PECAM-1 14.8
Cadherin and catenins
CDH1, CTNNA1, CTNNAL 1,
CTNNB1, CTNND1, CTNND2
3.3 to 5.9
Selectins
SELE, SELL, SELP 3.1 to 4.5
Others
CD44 3.2
Extracellular matrix proteins
CAV1, COL18A1, COL1A1, COL4A2,
ECM1, FGB, LAMB1, SPARC,
THBS1, THBS2, THBS3
2.6 to 3.5
LAMC1 +2.86
a The fold change was compared between HCMEC transduced with Ad-EGP
and Adh-gal. The change in hybridization signal was considered significant
when the average differences across the probe from three different
experiments was >2.0-fold. (): downregulation, (+): upregulation.
Fig. 3. EGP induces apoptosis in HCMEC. DNA extracted from endothelial
cells after 96 h of transduction with Ad-EGP (lane 1) or Adh-gal (lane 2)
was analyzed for internucleosomal DNA fragmentation by 1.4% agarose
gel electrophoresis. The migration of a standard DNA ladder (Bx174-Hae
III digest) is shown as a marker (lane M).
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similar analysis for genes representing the extracellular
matrix suggested no significant change in fibronectin-1
and vitronectin between experimental and control cells.
Interestingly, the LAMC1 level was increased approximate-
ly 2.8-fold in EGP-expressing cells, but 11 other genes
related to the extracellular matrix protein analyzed in the GE
array decreased approximately 2.6–3.5-fold in EGP-
expressing cells as compared to the h-gal control. Thus,
expression of EGP in HCMEC resulted in a global change
in many genes representing extracellular matrix proteins and
cell membrane adhesion molecules. These genes play a key
role in mediating many biological functions, as well as in
many diseases and pathophysiological processes. Their
altered level as a result of EGP expression would be
expected to lead to dramatic changes in multiple processes
such as cardiovascular disorders and an increase in the
overall rate of HCMEC cytotoxicity. Some of the target
genes we identified have also been implicated previously
for modulation at the protein level following expression of
EGP in 293T cells, Vero cells, human pulmonary artery
endothelial cells (HPAEC), and HUVEC (Simmons et al.,
2002; Takada et al., 2000).
Ebola virus glycoprotein expression induces apoptosis in
HCMEC
Our experimental observations suggested that EGP trans-
duction causes HCMEC cytotoxicity within 3–5 days. Webecame interested to examine the mechanism of cell death.
To investigate whether expression of EGP induces DNA
fragmentation, a hallmark of apoptosis, HCMECs were
transduced with either Ad-EGP or Adh-gal. After 96 h of
transduction, cells were lysed in 10 mM Tris (pH 8.0), 1
mM EDTA, 100 mM NaCl, 1.0% SDS, and 200 Ag/ml
proteinase K. Genomic DNA was isolated and analyzed by
agarose gel electrophoresis. Results exhibited a typical
apoptotic ladder indicating internucleosomal DNA fragmen-
tation in cells expressing EGP (Fig. 3). However, cells
transduced with control Adh-gal did not exhibit a detectable
DNA fragmentation. To further confirm apoptotic cell
death, we stained the transduced cells with Annexin V-
Cy5 (670 nm wavelength, BD Biosciences, CA). Confocal
microscopy of Ad-EGP-transduced HCMEC suggested
EGP localization on the cell surface (Fig. 4, panel B, red
color) and membrane phosphatidylserine exposure on the
outer leaflet of the plasma membrane (panel C, blue color).
The two fluorochromes (red and blue) appeared pink in
color when superimposed digitally (panel D), whereas GFP
expression appeared as a green color (panel A). Further
analysis indicated that apoptosis of HCMEC from EGP
expression did not induce activation of caspase 8, 9, 3, or
PARP cleavage. However, we observed a consistently
elevated level of procaspase 9 at the protein level (data
not shown). Whether accumulation of procaspase 9 is
related to cell rounding and death remains to be addressed
in future studies. Treatment of cells at various doses of z-
VAD, an inhibitor of effector caspases, did not inhibit DNA
fragmentation or cell death of Ad-EGP-transduced
HCMEC, suggesting downstream effector caspases may
not play a role.
Our results suggest that intracellular expression of EGP
causes apoptosis of HCMEC by induction of inappropriate
cell matrix interactions. Integrins are major mediators of
adhesion between cells and extracellular matrix (ECM)
proteins, and transduce signals for cell survival (Miranti
Fig. 4. EGP expression and Annexin V-Cy5 staining of apoptotic cells following transduction of HCMEC with Ad-EGP. Cells after transduction with Adh-gal
or Ad-EGP (20 moi) displayed GFP (panel A), cell surface expression of EGP by immunofluorescent staining with a specific monoclonal antibody (panel B),
and AnnexinV-Cy5 staining (panel C). Fluorescence images of panels A, B, and C were superimposed digitally for fine comparison (panel D). Confocal
microscopy suggested colocalization of EGP and phosphatidylserine at the external environment.
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as detachment from the matrix triggers apoptosis or anoikis
(Greek: state of homelessness) (Frisch and Screaton, 2001;
Grossmann, 2002). The central problem of anoikis is to
understand how integrin-mediated cell adhesion signals
control the apoptotic machinery. Cellular decision for anoi-
kis in mammary epithelial cells occurs in the absence of
caspase activation (Yang et al., 2000), and involvement of
anti- or proapoptotic protein molecules has been implicated
as one of the mechanisms (Reginato et al., 2003). There-
fore, we investigated the status of anti-apoptotic protein
Bcl2 in HCMEC-expressing EGP because Bcl2 is expressed
predominantly in these cells. Interestingly, Bcl2 expression
was significantly repressed in Ad-EGP-transduced HCMEC
as compared to Adh-gal-transduced cells (Fig. 5). Further
elucidation of the mechanisms underlying anoikis will
provide important insights into adhesion-mediated regula-
tion of cell death. This will allow the development of
inhibitors of EGP-mediated cytotoxicity and might help to
ameliorate the lethal effects of Ebola virus-mediated disease
progression.
In summary, our study suggested that transduction of
HCMEC with Ad-EGP causes loss of adhesion and cytotox-
icity. We have also observed that sensitivity of cell rounding
differs between HCMEC and HUVEC upon EGP expres-
sion. The reason for the different susceptibility between
these two endothelial cell lines for EGP-mediated changes
is not clear at this time. Loss of cell adhesion, particularly in
endothelial cells, may contribute to the hemorrhagic disease
characteristic of Ebola virus infection. On the other hand, a
reduction in MHC I and II surface levels (Baize et al., 2002;Harcourt et al., 1999) may play a role in the highly patho-
genic course of Ebola virus infection. We have observed a
downregulation of genes related to adhesion molecules in
HCMEC upon transduction with Ad-EGP from the cDNA
macroarray. Microscopic examination revealed that rounding
occurs for cells expressing EGP, suggesting that intracellular
expression of EGP is important for the cytopathic effect.
Because Marburg GP does not induce a similar detachment
of 293 cells like Zaire EGP (Chan et al., 2000b), the
observed effect of EGP appears to be specific. Moreover,
expression of EGP in monocyte–macrophage-derived THP-
1 cells did not induce cell death. EGP induces apoptotic cell
death in HCMEC, as evident from DNA fragmentation, and
annexin V staining. A subsequent study revealed that ex-
pression of Bcl2 is repressed upon EGP transduction in
HCMEC. Together, these results suggested that EGP induces
anoikis in HCMEC.
Apoptosis is a critical feature of coronary endothelial and
myocardial injury. Endothelial cell (EC) apoptosis markedly
enhances dendritic cell (DC) adhesion (Weis et al., 2002).
Because dendritic cells control immunity, regulating DC–
EC interaction may be relevant to inflammation and athero-
genesis. Thus, alterations in endothelial function have a
significant impact on DC adherence to endothelium. The
biologic effect of EGP alone may largely account for the
features of Ebola virus infection that leads to fatal disease,
including inflammatory dysregulation, immune suppression,
and loss of vascular integrity (Sullivan et al., 2003a). Results
from our study shed light on the pathophysiological con-
sequences induced by EGP in primary endothelial cells.
Further work should address the molecular mechanism(s)
Fig. 5. Inhibition of Bcl2 expression in HCMEC following Ad-EGP
transduction. HCMEC cells were transduced with Ad-EGP (lane 1) and
Adh-gal as a control (lane 2) at 20 moi. Cells were lysed 90 h after
transduction and examined for Bcl2 expression by Western blot analysis
using a specific rabbit antibody. The molecular weight of Bcl2 protein band
(23 kDa) was ascertained from the migration of standard protein molecular
weight markers (Invitrogen). The blot was reprobed with antibody to actin
(Santa Cruz) for comparison of protein load in each lane.
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function.Materials and methods
Cell lines and culture conditions
Primary human cardiac microvascular endothelial cells
(HCMEC) and human umbilical vein endothelial cells
(HUVEC) were procured from ScienCell Research Labora-
tories, CA. These primary cells were maintained in endo-
thelial cell culture medium (ScienCell) to selectively
promote growth at 37 jC in a 5% CO2 incubator. A human
monocyte–macrophage-derived cell line (THP-1) and hu-
man embryonic kidney (293) cells were obtained from
ATCC. THP-1 and 293 cells were grown in Dulbecco’s
modified Eagle’s medium containing 10% fetal bovine
serum at 37 jC in a 5% CO2 incubator.Antibodies
EGP-specific monoclonal antibodies (Wilson et al.,
2000) were kindly provided by Mary Kate Hart, US Army
Medical Research Institute of Infectious Diseases, Freder-
ick, MD. A rabbit polyclonal antibody to EGP (Jeffers et al.,
2002) was kindly provided by Anthony Sanchez, Centers
for Disease Control and Prevention, Atlanta, GA. These
antibodies were used in indirect immunofluorescence or
Western blot analysis. A rabbit antiserum to Bcl2 (Subra-
manian and Chinnadurai, 2003) was kindly provided by G.
Chinnadurai, Saint Louis University.
Recombinant adenovirus
A cDNA clone encoding the Ebola virus (Zaire)
glycoprotein (EGP) was kindly provided by H. D. Klenk,
Institute for Virology, Marburg, Germany. A recombinant
adenovirus for expression of EGP (Ad-EGP) was gener-
ated as described previously (Ghosh et al., 1999). Briefly,
the coding sequence of Ebola virus glycoprotein (Zaire)
was cloned into the pAdTrack-CMV shuttle vector under
the control of a CMV early promoter (He et al., 1998).
Human embryonic kidney (293) cells were transfected
with AdTrack-EGP, and EGP expression was detected
by Western blot analysis using specific rabbit antibody.
Cell surface expression of EGP in transfected 293 cells
was detected by indirect immunofluorescence using a
specific monoclonal antibody (13F6-1–2). These results
suggested the authenticity of the cloned DNA expressing
EGP in mammalian cells. Subsequently, AdTrack-EGP
plasmid DNA was linearized with PmeI restriction enzyme
and cotransformed into E. coli BJ5183 cells with
pAdEasy adenoviral backbone plasmid DNA. Recombi-
nants were selected and verified by restriction enzyme
endonuclease analyses. Finally, linearized plasmid DNA
was transfected into an adenovirus packaging cell line (293
cells) for the generation of recombinant adenovirus (Ad-
EGP). This recombinant adenovirus also expresses green
fluorescence protein (GFP) for monitoring transduction
efficiency.
cDNA array
A cDNA macroarray (GE Array, Q Series, SuperArray,
Inc., MD) corresponding to human extracellular matrix
and adhesion molecules printed on nylon membrane was
selected. Total HCMEC RNA was isolated from cells
using the Purescript RNA isolation kit (Gentra Systems,
MN) following the manufacturer’s protocol. A biotin-16-
dUTP cDNA probe was synthesized from total cellular
RNA by RT-PCR. The probe was added to the prehybri-
dized nylon membrane and hybridized overnight at 60 jC
with continuous agitation. The membrane was washed
and developed by the addition of alkaline phosphatase-
conjugated streptavidin and substrate, followed by chemi-
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X-ray film was scanned and converted into a TIF pro-
gram, and the data were analyzed using a software
provided by the manufacturer (ScanAlyze, SuperArray
Inc., MD).
Western blot analysis
Transfected or recombinant adenovirus-transduced
HCMECswere lysed and an equal amount of cellular proteins
was subjected to SDS-PAGE. Proteins were transferred onto
nitrocellulose membrane. The membrane was blocked with
non-fat dry milk (5%) in Tris-buffered saline containing
0.05% Tween 20 and incubated with a rabbit antiserum
(1:1000 dilution) to EGP for 2 h at room temperature. An
anti-rabbit immunoglobulin coupled to horseradish peroxi-
dase was used as the second antibody for detection of EGP by
chemiluminescence (ECL, Amersham). The molecular
weight of the EGP band in the immunoblot was estimated
from the migration of standard protein molecular weight
markers (Invitrogen).
Immunofluorescence study
Experimental cells were incubated with anti-EGP mouse
monoclonal antibody and stained with anti-mouse immuno-
globulin (Ig) conjugated with Alexa 568 (Molecular
Probes). After staining, cells were fixed with formaldehyde
(4%) and mounted for confocal microscopy (Bio-Rad model
1024). Whenever necessary, the images were superimposed
digitally to allow fine comparison. Colocalization of two
different color signals in a single pixel produces a distinct
color, whereas separated signals remain with individual
color. A control cell preparation was made similarly for
analysis using both the primary and the secondary anti-
bodies for comparison.Acknowledgments
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